Explore more Articles in

BioTech

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on the hope that trade deals might finally be announced as the Trump administration...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength against the . although at the moment the price still cannot break the...

What’s Going On With Hims & Hers Health Stock On Monday? – Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health, Inc. HIMS is currently experiencing a decline in its stock price, trading lower on Monday. The company’s stock has plummeted...

Why Is Cogent Biosciences Stock Trading Higher On Monday? – Cogent Biosciences (NASDAQ:COGT)

Cogent Biosciences, Inc.‘s COGT bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder. With statistically significant improvements...
BioTech

Scholar Rock’s Atrophy Drug When Combined With Eli Lilly’s Zepbound Shows Around 55% Better Muscle Preservation In Weight Loss Study – Scholar Rock Holding...

Scholar Rock SRRK revealed results on Wednesday from the Phase 2 EMBRAZE proof-of-concept trial assessing apitegromab in combination with tirzepatide to preserve lean mass during...
BioTech

Eli Lilly’s $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst – Eli Lilly (NYSE:LLY), Verve Therapeutics (NASDAQ:VERV)

On Tuesday, Eli Lilly And Co LLY agreed to acquire Verve Therapeutics, Inc. VERV, a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease.Lilly...
BioTech

AbbVie’s Migraine Drug Outperforms Generic Treatment In Head-To-Head Trial – AbbVie (NYSE:ABBV)

AbbVie Inc ABBV on Wednesday released topline results from its Phase 3 TEMPLE study evaluating the tolerability, safety, and efficacy of atogepant (QULIPTA/AQUIPTA, 60...
BioTech

Why Is Micro-Cap Aptevo Stock Trading Higher On Wednesday? – Aptevo Therapeutics (NASDAQ:APVO)

Aptevo Therapeutics Inc APVO stock is surging on Wednesday.As per data from Benzinga Pro, the stock is trading higher with a strong volume of...
BioTech

EXCLUSIVE: Telomir Pharmaceuticals Says Preclinical Drug Candidate Prevents Premature Aging In Patient-Derived Cells From Children With Progeria – Telomir Pharmaceuticals (NASDAQ:TELO)

Telomir Pharmaceuticals Inc. TELO on Wednesday announced new preclinical data showing that its lead candidate, Telomir-1, prevented cellular aging in human progeria cell lines...
BioTech

Biodexa Hits Key Milestone For Its Type 1 Diabetes Candidate Tolimidone, Enrolls First Patient In Phase 2a Study – Biodexa Pharmaceuticals (NASDAQ:BDRX), Pfizer (NYSE:PFE)

When it comes to type 1 diabetes, treating this chronic condition can be difficult. After all, with this type of diabetes, the body's immune...
1...141516...18Page 15 of 18

- A word from our sponsors -

Most Popular

Disclaimer: The content provided is for informational purposes only. We aim to keep the content current and accurate by updating it frequently. Sometimes the actual data can differ from what's stated on our website. Buttonwoodnews.com is an independent platform. While we are independent, we may be compensated for advertisements, sponsored products, or when you click on a link on our website. The contributors and authors are not registered or certified financial advisors. You should consult a financial professional before making any financial decisions.

Copyright © Button Wood News.